Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

PFIZER, INC.

(PFE)
  Report
Delayed Quote. Delayed Nyse - 07/23 04:10:00 pm
41.68 USD   +0.51%
12:19aEMEA MORNING BRIEFING : Stocks to Fall at Open, -2-
DJ
07/25NEWS HIGHLIGHTS : Top Company News of the Day
DJ
07/24DR Congo Faces Major Challenges in Covid-19 Vaccine Rollout
AQ
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

US, EU Vow to Provide COVID-19 Vaccine to Two-Thirds of World's Population by End of 2022

06/15/2021 | 02:10pm EDT


ę MT Newswires 2021
All news about PFIZER, INC.
12:19aEMEA MORNING BRIEFING : Stocks to Fall at Open, -2-
DJ
07/25NEWS HIGHLIGHTS : Top Company News of the Day
DJ
07/24DR Congo Faces Major Challenges in Covid-19 Vaccine Rollout
AQ
07/23Health Care Up Ahead Of Earnings -- Health Care Roundup
DJ
07/23S&P 500 Posts 2% Weekly Gain to Fresh Closing High, Led by Communication Serv..
MT
07/23THE LATEST : WH: US to buy 200M more doses of Pfizer vaccine
AQ
07/23PFIZER : Brazil reopens amid looming threat from delta variant
AQ
07/23Big tech companies retake market reins with earnings on tap
RE
07/23ARVINAS : Oppenheimer Adjusts Arvinas PT to $108 From $100, Maintains Outperform..
MT
07/23PFIZER : Governors pin hopes on full vaccine approval as cases climb
AQ
More news
Financials (USD)
Sales 2021 72 051 M - -
Net income 2021 17 125 M - -
Net Debt 2021 27 333 M - -
P/E ratio 2021 14,2x
Yield 2021 3,78%
Capitalization 233 B 233 B -
EV / Sales 2021 3,62x
EV / Sales 2022 4,11x
Nbr of Employees 78 500
Free-Float 59,2%
Chart PFIZER, INC.
Duration : Period :
Pfizer, Inc. Technical Analysis Chart | PFE | US7170811035 | MarketScreener
Technical analysis trends PFIZER, INC.
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 24
Last Close Price 41,68 $
Average target price 42,67 $
Spread / Average Target 2,38%
EPS Revisions
Managers and Directors
Albert Bourla Chairman, Chief Executive & Operating Officer
Frank A. D'Amelio Chief Financial Officer & EVP-Global Supply
Mikael Dolsten Chief Scientific Officer & Research President
Lidia L. Fonseca Executive VP, Chief Digital & Technology Officer
Aida Habtezion Chief Medical Officer
Sector and Competitors
1st jan.Capi. (M$)
PFIZER, INC.13.23%218 198
JOHNSON & JOHNSON9.16%432 430
ROCHE HOLDING AG12.39%325 975
ELI LILLY AND COMPANY44.60%209 276
NOVARTIS AG1.10%207 246
ABBVIE INC.10.30%199 548